Literature DB >> 1866557

Relapsing systemic infection due to Rhodococcus equi in a drug abuser seropositive for human immunodeficiency virus.

G Sirera1, J Romeu, B Clotet, P Velasco, J Arnal, F Rius, M Foz.   

Abstract

A case of recurrent multisystemic infection due to Rhodococcus equi in a patient with antibody to the human immunodeficiency virus (HIV) but without AIDS is reported. This case, which occurred in a woman with a history of alcohol and drug abuse, is, to our knowledge, the first such case described. The infection involved the lungs, kidneys, brain, and bloodstream. Despite several courses of therapy with antibiotics to which her isolates of R. equi were susceptible in vitro, the patient experienced multiple relapses before her death. On the basis of this case and a few others reported in HIV-infected patients, we recommend an initial antibiotic course at least 6-8 weeks in duration, and we suggest that combination antibiotic treatment be considered. We also suggest that infection with R. equi be included in the diagnostic criteria for AIDS.

Entities:  

Mesh:

Year:  1991        PMID: 1866557     DOI: 10.1093/clinids/13.3.509

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

1.  In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.

Authors:  A Giacometti; O Cirioni; F Ancarani; M S Del Prete; M Fortuna; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Acute mediastinitis due to Rhodococcus equi in a patient with human immunodeficiency virus infection.

Authors:  J L Casado; A Antela; J A Sanchez; J M Hermida; M Meseguer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

3.  Radiological findings in nine AIDS patients with Rhodococcus equi pneumonia.

Authors:  S Wicky; F Cartei; B Mayor; J Frija; P A Gevenois; J Giron; F Laurent; G Perri; P Schnyder
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Penicillin-binding proteins of Rhodococcus equi: potential role in resistance to imipenem.

Authors:  P Nordmann; M H Nicolas; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

6.  Virulence of Rhodococcus equi isolates from patients with and without AIDS.

Authors:  S Takai; Y Sasaki; T Ikeda; Y Uchida; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 7.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

8.  Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.

Authors:  M M McNeil; J M Brown
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Therapy of Rhodococcus equi disseminated infections in nude mice.

Authors:  P Nordmann; J J Kerestedjian; E Ronco
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

10.  [A 52-year-old woman with acute shock and purpura fulminans. Pneumococcal sepsis].

Authors:  E Jochum; A Perez-Bouza; S Baumanns; J vom Dahl; U Janssen
Journal:  Internist (Berl)       Date:  2008-06       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.